The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 361:1812-1813 October 29, 2009 Number 18
NextNext

Cumulative Live-Birth Rates in a Trial of Single-Embryo or Double-Embryo Transfer

 

This Article
- PDF
-PDA Full Text
-Supplementary Material

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: We previously reported in the Journal1 the results of a randomized, controlled trial comparing pregnancy outcomes in patients undergoing in vitro fertilization (IVF) involving a fresh single-embryo transfer followed, if no live birth occurred after the fresh-embryo cycle, by a frozen-thawed single-embryo transfer with patients undergoing IVF involving a fresh double-embryo transfer. As compared with the rates in the double-embryo-transfer group, in the single-embryo-transfer group, the live-birth rate was not substantially lower and the multiple-birth rate was significantly lower.1 Multiple birth is considered to be the main risk associated with IVF because of the increased rate of adverse perinatal outcomes.2,3

The present study investigated the cumulative live-birth rates in the two groups after the inclusion of all frozen-thawed cycles after the fresh-embryo cycle. The cumulative live-birth rate was defined as the number of women with a pregnancy resulting in at least one live birth divided by the number of women who underwent randomization. In the additional frozen-thawed cycles, one or two embryos were transferred, without regard to the original randomization group. All 661 patients who participated in the randomized trial were included; none of the patients were lost to follow-up, and all embryos were accounted for (Figure 1).

Figure 1
View larger version (17K):
[in this window]
[in a new window]
Get Slide
 
Figure 1. Enrollment and Outcomes.

The patients in the single-embryo-transfer group underwent one fresh single-embryo transfer, and if no live birth occurred after one cycle, these patients underwent one frozen-thawed single-embryo transfer. Patients in the double-embryo-transfer group underwent one fresh double-embryo transfer. Twenty-nine patients in the single-embryo-transfer group and 18 patients in the double-embryo-transfer group had pregnancies resulting in two live births. One woman in the double-embryo-transfer group had a pregnancy resulting in three live births. The 48 pairs of twins in the double-embryo-transfer group after the first cycle included three twin pregnancies in which one fetus died in utero between 24 and 27 weeks of gestational age.

 
The cumulative live-birth rates were 43.9% (145 of 330 patients) in the single-embryo-transfer group and 51.1% (169 of 331 patients) in the double-embryo-transfer group (difference, 7.1%; 95% confidence interval [CI], –0.6 to 14.8; P=0.08). The mean rate of live births was 53% (174 of 330 patients) in the single-embryo-transfer group and 57% (189 of 331 patients) in the double-embryo-transfer group (P=0.20). The multiple-birth rate was significantly lower in the single-embryo-transfer group than in the double-embryo-transfer group (2.3% vs. 27.5%; difference, 25.2%; 95% CI, 15.1 to 35.0; P<0.001). The rate of preterm birth (<37 full weeks of gestational age) was significantly higher in the double-embryo-transfer group as compared with the single-embryo-transfer group (25.5% vs. 11.8%; difference, 13.7%; 95% CI, 4.0 to 23.2; P<0.001) (see Table I in the Supplementary Appendix, available with the full text of this letter at NEJM.org).

The use of cumulative live-birth rates instead of outcome per cycle has advantages for the patient, since it better summarizes her chance of a live birth over an entire treatment period.4 We found that the cumulative live-birth rate after one oocyte retrieval was high in both groups. It was lower in the single-embryo-transfer group than in the double-embryo-transfer group, although not significantly so. The advantage of single-embryo transfer is the dramatically reduced rate of multiple births as compared with double-embryo transfer. A well-functioning cryopreservation program is a prerequisite to implementation of a single-embryo-transfer strategy and should be encouraged.5


Ann Thurin-Kjellberg, M.D., Ph.D.
Catharina Olivius, M.D.
Christina Bergh, M.D., Ph.D.
Gothenburg University
Gothenburg, Sweden
ann.thurin{at}vgregion.se

Supported by Sahlgrenska Academy, Sahlgrenska University Hospital, and the Göteborg Medical Society.

Dr. Thurin-Kjellberg reports receiving lecture fees from Merck Serono, Schering-Plough, and Ferring, and consulting fees from Merck Serono Sweden; and Dr. Bergh, lecture fees from Merck Serono, Schering-Plough, and Ferring. No other potential conflict of interest relevant to this letter was reported.

References

  1. Thurin-Kjellberg A, Hausken J, Hillensjö T, et al. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med 2004;351:2392-2402. [Free Full Text]
  2. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002;346:731-737. [Free Full Text]
  3. Wennerholm UB, Bergh C. Outcome of IVF pregnancies. Fetal Matern Med Rev 2004;15:27-57.
  4. Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med 2009;360:236-243. [Free Full Text]
  5. Veleva Z, Karinen P, Tomás C, Tapanainen J, Martikainen H. Elective single embryo transfer with cryopreservation improves the outcome and diminishes the costs of IVF/ICSI. Hum Reprod 2009;24:1632-1639. [Free Full Text]

 

This Article
- PDF
-PDA Full Text
-Supplementary Material

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.